MIBI is the sterile non-radioactive lyophilizate that is intended for use after the labelling with Technetium-99m. Radiopharmaceuticals are prepared directly before it use in the clinics and medical centers
Designation: is suitable agent for estimation the myocardial perfusion in various pathological processes that lead to the disorder of the blood supply (coronary atherosclerosis, acute myocardial infarction, post-infarction and post myocarditis cardiosclerosis, coronary heart disease), as well as to visualize the malignant tumors of lungs and breast
Cold kit expiry: 12 months after the production date Radiopharmaceutical expiry: 5 hours since the preparation